Page 46 - துலேன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The test address the need to expand testing capacity in community-based settings The new test uses the same CRISPR-based approach that the researchers have submitted to the Food and Drug Administration for Emergency Use Authorization. Rapid PCR tests typically use nasal swab samples and are performed in laboratory settings by highly trained individuals using sophisticated equipment. The new saliva-based COVID-19 test, which doesn’t require lab processing, could rapidly expand testing capacity in outpatient clinics, community testing sites, and other locations. The assay the researchers developed detects SARS-CoV-2 virus RNA in saliva to diagnose COVID-19 and is more sensitive than PCR-based tests, the current gold standard for COVID-19 diagnosis. A report describing the development and validation of the test appears in

Drug administration for emergency use authorizationTulane university school of medicineDrug administrationEmergency useTulane university schoolதுலேன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்துஅவசரம் பயன்பாடுதுலேன் பல்கலைக்கழகம் பள்ளி